The ANZUP ASM provides a platform for members to present their research, learn about new and existing ANZUP trials and hear about the most up-to-date management of GU cancers.
Message from Convenor Henry Woo
This Annual Scientific Meeting, more so than any other, is a coming of age for ANZUP and it is for that reason I am delighted to be the 2018 Convenor. As we celebrate our 10th anniversary year, the 7th standalone ANZUP ASM is an opportunity to reflect on the achievements over the last decade. For an organisation which basically started from scratch in 2008, to now being recognised internationally for our clinical trials is a truly outstanding accomplishment.
Stepping away from the current trend of big data, the #ANZUP18 theme ‘Putting People First’ will focus on the management of GU cancers from a holistic, people-centric perspective. While big data sets have an important place in identifying trends and associations between disease factors, they can also lose sight of the individual. Putting People First means focusing on patients, carers and every individual involved in the multidisciplinary care of patients and clinical trials research. It is a sentiment which not only reflects ANZUP’s priorities but is also a tribute to the many individuals who have made ANZUP what it is today.
While popular sessions such as the Translational Research Symposium, PCFA Nurses Symposium, MDT Masterclasses and Community Engagement Forum will return in 2018, delegates can also expect to be wowed with novel ways of content delivery. When we think about the way we approach cancer, it’s ever changing and so should the way we share and deliver educational content. If nothing else, know you should expect the unexpected!
The convening committee has secured an amazing international faculty, bringing together a mix of key opinion leaders and up and coming clinicians. While all bring great value in their areas of expertise, they have also been selected for their patient focus and fit with the engaging and supportive spirit of ANZUP and our ASMs.
Urologist Angie Smith has seen a meteoric rise in the US thanks to her work in bladder cancer and patient outcomes. She’s also an advocate for patient care and the importance of doctors’ own health. I have no doubt she will bring a real breath of fresh air to Sydney. While Laurence Albiges, a medical oncologist from Gustave Roussy, Paris, is representative of how much of an impact European cancer research is having on our day-to-day practice.
We will also welcome radiation oncologist Tamim Niazi from Montreal, medical oncologist Sumanta (Monty) Kumar Pal from California and two internationally renowned members of the ANZUP Scientific Advisory Committee – medical oncologist Chris Sweeney and urologist Bertrand Tombal.
Why should delegates register for #ANZUP18? Things are changing in uro-oncology at breakneck speed to the extent that even taking a year off from work in this area would have you feeling outdated. If you want to be where it’s all happening, this is where you need to be.
I look forward to welcoming you to Sydney.
Convenor, 2018 ANZUP Annual Scientific Meeting
Highlights will include:
• State of the art presentations from leading international and Australian experts
• Up-to-date management and research for prostate and other genitourinary cancers
• PCFA ANZUP Nurses Symposium
• Translational Research Symposium
• Clinical trial Concept Development Workshop
• Overviews of current and planned ANZUP trials
• ANZUP MDT Masterclass where delegates have the opportunity to have questions answered by expert panels
• Community Engagement Forum: A little below the belt
• Travel Fellowships will be available for ANZUP members (details to be confimed)
The 2018 ASM promises an outstanding international faculty
Confirmed speakers include:
Tamim Niazi Radiation Oncologist at the Jewish General Hospital, Montreal, Canada and Assistant Professor of the Department of Oncology, McGill University, Montreal, Canada
Angie Smith Assistant Professor of Urology at the UNC Department of Urology and member of the UNC Lineberger Comprehensive Cancer Center, North Carolina, US
Laurence Albiges Medical Oncologist and Head of Genitourinary Unit of the Department of Cancer Medicine, Gustave Roussy, France
Bertrand Tombal Chair the Division of Urology and Professor of Urology at the Université catholique de Louvain (UCL), Cliniques universitaires Saint-Luc, Brussels, Belgium (member of the ANZUP Scientific Advisory Committee)
Chris Sweeney Medical Oncologist at the Dana-Farber Cancer Institute, US (member of the ANZUP Scientific Advisory Committee)
Sumanta (Monty) Kumar Pal – Associate Clinical Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, California, US